Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients

@inproceedings{Akalin2014PrognosticIO,
  title={Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients},
  author={Nilg{\"u}l Akalin and Yıldız Okuturlar and {\"O}zlem Harmankaya and Asuman Gedikbaşı and Selcuk Sezikli and Sibel Koçak Y{\"u}cel},
  booktitle={International journal of nephrology},
  year={2014}
}
Introduction. In this study, we aimed to demonstrate the correlation of FGF-23 levels with bone-mineral metabolism, anemia, and the treatment in dialysis patients. Methods. Eighty-nine patients with similar age, gender, dialysis duration, and dialysis adequacy who were receiving hemodialysis replacement therapy for at least 6 months were included in the study. Serum iron, iron binding capacity, ferritin, hemoglobin (Hb), hematocrit (Htc), calcium (Ca), phosphorus (P), intact parathormone (iPTH… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

Fibroblast growth factor 23 — structure , function and role in kidney diseases

M. Olszanecka-Glinianowicz Kocełak, J. Chudek
  • Advances in Clinical and Experimental Medicine
  • 2012

Fibroblast growth factor 23--structure, function and role in kidney diseases.

  • Advances in clinical and experimental medicine : official organ Wroclaw Medical University
  • 2012
VIEW 1 EXCERPT

F

A.L.E. Cancela, R. B. Oliveira
  • G. Graciolli et al., “Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate,” Nephron—Clinical Practice, vol. 117, no. 1, pp. c74–c82
  • 2011
VIEW 1 EXCERPT

and H

H. Sliem, G. Tawfik, F. Moustafa
  • Zaki, “Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study,” Indian Journal of Endocrinology and Metabolism, vol. 15, no. 2, pp. 105–109
  • 2011
VIEW 1 EXCERPT

H

E. Ashikaga, H. Honda
  • Suzuki et al., “Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients,” Therapeutic Apheresis and Dialysis, vol. 14, no. 3, pp. 315–322
  • 2010

H

H. Komaba, S. Goto
  • Fujii et al., “Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients,” Kidney International, vol. 77, no. 3, pp. 232–238
  • 2010
VIEW 3 EXCERPTS